2-(Bromomethyl)imidazo[1,2-a]pyrimidine hydrobromide, 98%, 1g

4-(2-Fluoropyridin-3-yl)-2-(methylthio)pyrimidine, 95%, 1g

(R)-2-Amino-3,3-diphenylpropan-1-ol, 95%, 100mg

1-Phenyl-1-cyclopropyl ethanol, 97.0%, 250mg

ethyl (2Z)-2-chloro-2-[2-(4-phenoxyphenyl)hydrazin-1-ylidene]acetate, 95.0%, 2g

(S)-2-((tert-Butoxycarbonyl)amino)-3-mercaptopropanoic acid, 95.0%, 1g

3-Piperidinecarboxylic Acid>98.0%(T)500g

Butanedioic acid, compd. with 4-amino-5-chloro-2,3-dihydro-N-[1-(3-methoxypropyl)-4-piperidinyl]-7-benzofurancarboxamide (1:1), 98.50%, 250mg

2-Amino-3-mesitylpropanoic acid, 98%, 500mg

3-Bromo-5-iodoanisole, 1g

2-Propanol, min. 99.5%, for synthesis, 2.5 l, glass packaging

2-Bromo-N-{3-[(4-methoxyphenyl)methoxy]phenyl}thieno[3,2-b]pyridin-7-amine, 97%, 250mg

Cytochrome C, min. 90%, for biochemistry, 100 mg, glass packaging